Randomized study of an auto-titration device (Somnoset®) vs. manual CPAP titration Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
A randomised crossover trial investigating the effect of a portable positive pressure ventilation device on exercise tolerance in patients with COPD Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018
Efficacy of temporary positive expiratory pressure to assist patients with chronic hypersecretion. A multicentre randomised trial Source: Annual Congress 2010 - Mucous clearance and treatment modalities in respiratory physiotherapy Year: 2010
Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques (ACBT) versus a new device Source: Eur Respir J 2004; 24: Suppl. 48, 406s Year: 2004
Randomised controlled trial of polysomnographic titration of noninvasive ventilation Source: Eur Respir J, 53 (5) 1802118; 10.1183/13993003.02118-2018 Year: 2019
Fixed pressure (FP) versus auto-adjusting continuous positive airway pressure (autoCPAP): Comparison of efficacy in reducing blood pressure, a randomized controlled trial Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Individualized flow controlled ventilation compared to pressure controlled ventilation in one lung ventilation – a prospective, randomized porcine study Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes Year: 2020
Self-proning in COVID-19 patients on low-flow oxygen therapy: a cluster randomised controlled trial Source: ERJ Open Res, 7 (1) 00692-2020; 10.1183/23120541.00692-2020 Year: 2021
High flow nasal cannula during walking in severe COPD patients: a randomized controlled trial. Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018
Randomised controlled trial of nasal continuous positive airways pressure (CPAP) in severe bronchiolitis Source: Eur Respir J 2005; 26: Suppl. 49, 27s Year: 2005
Impact of humidification in patients treated with home noninvasive ventilation (NIV): a randomised controlled trial Source: International Congress 2019 – New strategies to treat respiratory failure Year: 2019
Short-term effect of a single dose of inhaled procaterol on exercise performance in COPD: a randomized, double blind, placebo-controlled, crossover trial Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008
Self-proning in COVID-19 patients on low-flow oxygen therapy. A cluster randomised controlled trial Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021
Algorithm-based versus titrated CPAP: a randomized study Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008
Comparison of continuous versus various demand oxygen delivery systems during standardized walking in COPD – a single-blinded, randomized, cross-over study Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration Year: 2019
Randomized trial of 6 auto-adapting CPAP devices Source: Annual Congress 2011 - Sleep and weight: heavy under pressure Year: 2011
External heated humidification during non-invasive ventilation set up: results from a pilot cross-over clinical trial Source: Eur Respir J, 55 (5) 1901126; 10.1183/13993003.01126-2019 Year: 2020
Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial Source: Eur Respir J, 54 (5) 1900983; 10.1183/13993003.00983-2019 Year: 2019
Quality of life in patients with COPD and nocturnal supplemental oxygen-therapy: a prospective, placebo-controlled cross-over trial Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005
A multicenter, randomized, double-blind, double-dummy, 2-way crossover, single dose study, comparing the efficacy and safety of the fluticasone/salmeterol (500/50 μg) combination administered with the new Elpenhaler inhalation device versus the innovative one in patients with asthma Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009